Kathryn Connor

ORCID: 0000-0002-3755-5435
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intensive Care Unit Cognitive Disorders
  • Traffic and Road Safety
  • Nosocomial Infections in ICU
  • Anesthesia and Sedative Agents
  • Anesthesia and Neurotoxicity Research
  • Clostridium difficile and Clostridium perfringens research
  • Pharmaceutical Practices and Patient Outcomes
  • Antibiotics Pharmacokinetics and Efficacy
  • Respiratory Support and Mechanisms
  • Renal function and acid-base balance
  • Quality and Supply Management
  • Innovations in Medical Education
  • Sepsis Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Pharmacy and Medical Practices
  • Pneumonia and Respiratory Infections
  • Agriculture and Farm Safety
  • Cardiac, Anesthesia and Surgical Outcomes
  • Hematological disorders and diagnostics
  • Potassium and Related Disorders
  • Innovative Approaches in Technology and Social Development
  • Scheduling and Optimization Algorithms
  • Intramuscular injections and effects

St. John Fisher College
2010-2024

American College of Clinical Pharmacy
2010-2021

University of Rochester Medical Center
2010-2019

United States Army
2019

University of Rochester
2018

Training Programs in Epidemiology and Public Health Interventions Network
2015

Glasgow Victoria Infirmary
2010

University of Tennessee Health Science Center
2010

The response of ICU patients to continuously infused ketamine when it is used for analgesia and/or sedation remains poorly established.To describe continuous infusion (CI) use in critically ill patients, including indications, dose and duration, adverse effects, patient outcomes, time goal pain/sedation score range, exposure analgesics/sedatives, delirium.Multicenter, retrospective, observational study from twenty-five diverse institutions the United States. Patients receiving CI between...

10.1097/cce.0000000000000633 article EN cc-by-nc-nd Critical Care Explorations 2022-02-01

With the continuing evolution of pharmacy as a clinical profession, need to prepare well‐trained clinicians beyond knowledge gained from doctor degree program is magnified. Such training afforded by residency programs, which have expanded hospital sites practice settings diverse managed care organizations and public health departments. Although resident benefits intensive program, sponsoring institution also derives many hosting residency. Fundamentally, residents are licensed pharmacists...

10.1592/phco.30.12.1313 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2010-11-29

Motor vehicle crashes account for a large number of deaths and injuries. In the United States, in 2015, more than 35,000 people were killed approximately 2.44 million injured motor crashes. 2010, economic costs associated with States substantial, estimated to be $242 billion. Fortunately, wide range evidence-based interventions, including both policies programs, can help prevent vehicle-related injuries deaths. 2014, RAND researchers developed an online tool, Vehicle Prioritizing...

10.7249/tl144.2 article EN RAND Corporation eBooks 2018-01-01

Background: Older reports of use hydrochloric acid (HCl) infusions for treatment metabolic alkalosis document variable dosing strategies and risk. Objectives: This study sought to characterize HCl in surgical intensive care unit patients the alkalosis. Methods: retrospective review included who received a infusion >8 hours. The primary end point was evaluate utility common acid-base equations predicting dose requirements. Secondary points evaluated adverse effects, efficacy, duration...

10.1177/1060028018754389 article EN Annals of Pharmacotherapy 2018-01-23

A global crisis of antibiotic resistance is ongoing, especially with resistant gram-negative pathogens including Pseudomonas spp, carbapenemase-producing Enterobacteriaceae, and extended-spectrum β-lactamase (ESBL)-producing organisms. The increasing rate methicillin-resistant Staphylococcus aureus (MRSA) infections also a concern.1 One newer intravenous cephalosporin (ceftaroline) was approved in 2010, 2 new cephalosporin–β-lactamase inhibitor combinations (ceftolozane-tazobactam...

10.4037/aacnacc2016612 article EN AACN Advanced Critical Care 2016-10-01

Thrombocytopenia is a common occurrence in the critically ill population [1]. We aimed to determine incidence, severity and prognosis of thrombocytopenia our ICU.

10.1186/cc8597 article EN cc-by Critical Care 2010-01-01

Background: Guidelines advise that patients with ventilator-associated pneumonia (VAP) should respond clinically by Day 3 of antibiotics. White blood cell (WBC) count, maximum temperature (Tmax), and PaO2:FIO2 ratio are all said to significantly 6. Resolution abnormalities has not been evaluated in trauma patients. Methods: Retrospective review VAP. The WBC Tmax, were for 16 days after diagnosis. Patients grouped into uncomplicated VAP, complicated VAP (those inadequate empirical therapy...

10.1089/sur.2011.128 article EN Surgical Infections 2013-02-01

The vision for the future of pharmacy practice is that pharmacists will be acknowledged as health care professionals responsible medication-use outcomes and disease management clinical practitioners become board-certified specialists.1 Board Pharmacy Specialties (BPS) credentialing body provides this specialty certification. BPS certification a voluntary, peer-developed process in which pharmacists’ education, experience, knowledge, skills particular area are confirmed by examination, beyond...

10.2146/ajhp090209 article EN American Journal of Health-System Pharmacy 2010-06-30

Despite improved management and prevention strategies, nosocomial pneumonia remains a cause of morbidity mortality in critically ill patients; it is leading death among patients with hospital-acquired infections common source sepsis.1 Critical care clinicians must recognize that most cases (HAP) occur outside the intensive unit (ICU), so risk factors empiric antibiotic choices need to be considered carefully, especially as are being transitioned ICU. Furthermore, an episode...

10.4037/aacnacc2018486 article EN AACN Advanced Critical Care 2018-03-01

Describe continuous infusion (CI) ketamine practices in pediatric intensive care units (PICUs) and evaluate its effect on pain/sedation scores, exposure to analgesics/sedatives, adverse effects (AEs).

10.1155/2024/6626899 article EN cc-by Critical Care Research and Practice 2024-01-01

Groth, Christine1; Droege, Chris2; Connor, Kathryn3; Kaukeinen, Kimberly4; Acquisto, Nicole5; Chui, Sai Ho6; Cucci, Michaelia7; Dixit, Deepali8; Flannery, Alexander9; Gustafson, Kyle10; Glass, Nina11; Horng, Helen12; Heavner, Mojdeh13; Kinney, Justin14; Kruer, Rachel15; Peppard, William16; Sarangarm, Preeyaporn17; Newsome, Andrea18; Viswesh, Velliyur19; Erstad, Brian20 Author Information

10.1097/01.ccm.0000618692.88404.95 article EN Critical Care Medicine 2019-12-18

Clostridioides (formerly Clostridium) difficile infection recurrence in patients re-exposed to antibiotics for treatment of a non-Clostridioides is high at approximately 33%. Low-dose per os vancomycin (e.g. 125 mg q12 h) or metronidazole 500 intravenous/per osq8 may help prevent recurrences, but study secondary prophylaxis critically ill needed.To determine whether adults receiving low-dose have fewer recurrences 90 days compared with control (no prophylaxis).This was retrospective,...

10.1177/2050312120930898 article EN cc-by-nc SAGE Open Medicine 2020-01-01

Current evidence for dexmedetomidine-suspected fever (DSF) is limited. Lack of recognition may lead to costly or potentially harmful interventions critically ill patients.The primary objective was characterize escalations care related DSF. Secondary objectives were describe the incidence, severity, and consequences associated with DSF.A retrospective review conducted in adults who developed ≥39°C within 12 h from initiation dexmedetomidine, resolution <39°C after discontinuation. The outcome...

10.1177/10600280211060082 article EN Annals of Pharmacotherapy 2022-01-06

Groth, Christine1; Connor, Kathryn2; Kaukeinen, Kimberly3; Acquisto, Nicole4; Chui, Sai Ho5; Cucci, Michaelia6; Dixit, Deepali7; Droege, Chris8; Flannery, Alexander9; Gustafson, Kyle10; Glass, Nina11; Horng, Helen12; Heavner, Mojdeh13; Kinney, Justin14; Kruer, Rachel15; Peppard, William16; Sarangarm, Preeyaporn17; Newsome, Andrea18; Viswesh, Velliyur19; Erstad, Brian20 Author Information

10.1097/01.ccm.0000633372.54294.d8 article EN Critical Care Medicine 2019-12-18
Coming Soon ...